EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Delivery of miR-200c-3p Using Tumor-Targeted Mesoporous Silica Nanoparticles for Breast Cancer Therapy

Iris Garrido-Cano iD, Anna Adam-Artigues, Ana Lameirinhas, Juan F Blandez, Vicente Candela-Noguera, Ana Lluch, Begoña Bermejo, Felix Sancenón iD, Juan Miguel Cejalvo, Ramón Martínez-Máñez iD, Pilar Eroles

ACS Applied Materials & Interfaces · 2023

DOI: 10.1021/acsami.3c07541 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2023. Verfasst von Iris Garrido-Cano und 10 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Research Institute INCLIVA, Valencia 46010, Spain. Hauptthemen laut MEDLINE: MicroRNAs, Lung Neoplasms, Nanoparticles. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Generalitat Valenciana, European Commission, Ministerio de Ciencia e Innovación.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite advances in breast cancer treatment, it remains the leading cause of cancer-related death in women worldwide. In this context, microRNAs have emerged as potential therapeutic targets but still present some limitations for in vivo applications. Particularly, miR-200c-3p is a well-known tumor suppressor microRNA that inhibits tumor progression and metastasis in breast cancer through downregulating ZEB1 and ZEB2. Based on the above, we describe the design and validation of a nanodevice using mesoporous silica nanoparticles for miR-200c-3p delivery for breast cancer treatment. We demonstrate the biocompatibility of the synthesized nanodevices as well as their ability to escape from endosomes/lysosomes and inhibit tumorigenesis, invasion, migration, and proliferation of tumor cells in vitro. Moreover, tumor targeting and effective delivery of miR-200c-3p from the nanoparticles in vivo are confirmed in an orthotopic breast cancer mouse model, and the therapeutic efficacy is also evidenced by a decrease in tumor size and lung metastasis, while showing no signs of toxicity. Overall, our results provide evidence that miR-200c-3p-loaded nanoparticles are a potential strategy for breast cancer therapy and a safe and effective system for tumor-targeted delivery of microRNAs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsLung NeoplasmsNanoparticlesFemaleMiceAnimalsSilicon DioxideCell Line, TumorGene Expression Regulation, NeoplasticCell MovementCell Proliferation

Stichwörter der Autor:innen

breast cancermesoporous silica nanoparticlesmicroRNAtargeted deliverytherapy

Substanzen

Silicon DioxideMicroRNAs

Autor:innen und Institutionen

  • Biomedical Research Institute INCLIVA, Valencia 46010, Spain.
  • Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM), Universitat Politècnica de València, Universitat de València, Valencia 46010, Spain.
  • CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid 28029, Spain.
  • Unidad Mixta de Investigación en Nanomedicina y Sensores, Universitat Politècnica de València, IIS La Fe, Valencia 46026, Spain.
  • Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid 28029, Spain.
  • Universitat de València, Valencia 46010, Spain.

ORCID-Profile: Iris Garrido-Cano, Felix Sancenón, Ramón Martínez-Máñez

Förderung

  • Generalitat Valenciana
  • European Commission
  • Ministerio de Ciencia e Innovación
  • Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina
  • European Regional Development Fund
  • Ministerio de Economía y Competitividad
  • Fundación Científica Asociación Española Contra el Cáncer
  • Sociedad Española de Oncología Médica

Zitieren

APA

Garrido-Cano, I., Adam-Artigues, A., Lameirinhas, A., Blandez, J. F., Candela-Noguera, V., Lluch, A., Bermejo, B., Sancenón, F., Cejalvo, J. M., Martínez-Máñez, R., & Eroles, P. (2023). Delivery of miR-200c-3p Using Tumor-Targeted Mesoporous Silica Nanoparticles for Breast Cancer Therapy. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.3c07541

Vancouver

Garrido-Cano I, Adam-Artigues A, Lameirinhas A, Blandez JF, Candela-Noguera V, Lluch A, et al. Delivery of miR-200c-3p Using Tumor-Targeted Mesoporous Silica Nanoparticles for Breast Cancer Therapy. ACS Applied Materials & Interfaces. 2023. doi:10.1021/acsami.3c07541

BibTeX
@article{GarridoCano2023,
  author = {Garrido-Cano, Iris and Adam-Artigues, Anna and Lameirinhas, Ana and Blandez, Juan F and Candela-Noguera, Vicente and Lluch, Ana and Bermejo, Begoña and Sancenón, Felix and Cejalvo, Juan Miguel and Martínez-Máñez, Ramón and Eroles, Pilar},
  title = {Delivery of miR-200c-3p Using Tumor-Targeted Mesoporous Silica Nanoparticles for Breast Cancer Therapy},
  journal = {ACS Applied Materials & Interfaces},
  year = {2023},
  doi = {10.1021/acsami.3c07541}
}
Kostenlos starten →